ASTRAZENECA PHARMACEUTICALS LP

• ASTRAZENECA PHARMACEUTICALS LP $9,870,000 In-house, the client's own filings · 7 filings
• W STRATEGIES, LLC $560,000 Outside firm · 7 filings
• TODD STRATEGY GROUP $400,000 Outside firm · 6 filings
• THOLOS GOVERNMENT RELATIONS $20,000 Outside firm · 2 filings
• PRIME POLICY GROUP $0 Outside firm · 1 filing

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• H.R. 946
  ORPHAN Cures Act
  17 filings
• H.R. 1414
  Cameron’s Law
  7 filings
• H.R. 1990
  American Innovation and R&D Competitiveness Act of 2025
  6 filings
• H.R. 591
  Defending American Jobs and Investment Act
  6 filings
• H.R. 1
  One Big Beautiful Bill Act
  5 filings
• H.R. 1262
  Mikaela Naylon Give Kids a Chance Act
  5 filings
• H.R. 4132
  Prescription Information Modernization Act of 2025
  4 filings
• H.R. 2423
  Unfair Tax Prevention Act
  3 filings
• H.R. 3521
  Clinical Trial Modernization Act
  3 filings
• H.R. 9599
  SECURE 340B Act
  3 filings
• S. 864
  HELP Copays Act
  3 filings
• S. 998
  Medical Supply Chain Resiliency Act
  3 filings
• H.R. 1672
  Maintaining Investments in New Innovation Act
  2 filings
• H.R. 5509
  Safe Step Act
  2 filings
• H.R. 6166
  Lowering Drug Costs for American Families Act
  2 filings
• H.R. 7118
  Genomic Answers for Children’s Health Act of 2026
  2 filings
• S. 1605
  International Competition for American Jobs Act
  2 filings
• H.R. 1503
  Prescription Information Modernization Act of 2023
  1 filing
• H.R. 4695
  Unfair Tax Prevention Act
  1 filing
• H.R. 1911
  To amend the Internal Revenue Code of 1986 to provide that certain payments to foreign related parties subjec…
  1 filing
• H.R. 5376
  Impacts and Outcomes for Health Career Training Act
  1 filing
• S. 1639
  American Innovation and Jobs Act
  1 filing
• S. 1862
  ORPHAN Cures Act
  1 filing
• S. 2903
  Safe Step Act
  1 filing
• S. 3841
  Last Sale Valuation Act of 2026
  1 filing
• S. 4440
  Clinical Trial Modernization Act
  1 filing

• 2026 $5,270,000 11 filings
• 2025 $5,580,000 12 filings

• Medicare/Medicaid 20
• Health Issues 14
• Pharmacy 9
• Copyright/Patent/Trademark 8
• Taxation/Internal Revenue Code 7
• Tariff (miscellaneous tariff bills) 6
• Trade (domestic/foreign) 5
• Labor Issues/Antitrust/Workplace 2
• Insurance 1
• Manufacturing 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 19
• SENATE 18
• Centers For Medicare and Medicaid Services (CMS) 11
• White House Office 11
• U.S. Trade Representative (USTR) 7
• Health & Human Services, Dept of (HHS) 6
• Commerce, Dept of (DOC) 5
• Health Resources & Services Administration (HRSA) 3
• Intl Trade Administration (ITA) 3
• Bureau of Industry and Security (BIS) 2
• Labor, Dept of (DOL) 1
• State, Dept of (DOS) 1
• Treasury, Dept of 1

• ASTRAZENECA PLC United Kingdom named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.